Document Detail

Data exchange in the European pharmacovigilance.
MedLine Citation:
PMID:  10164092     Owner:  NLM     Status:  MEDLINE    
Recent research work on feasible solutions for electronic data exchanges in the european pharmacovigilance domain (EPhV) has facilitated a better understanding on strategic and operational factors inherent to such a class of transnational vigilance information systems. Most of the material presented here has resulted from the CARE-Pharmacovigilance Pilot project of the ENS-Telematics Programme, and from other subsequent research activities like the IDA feasibility study and the TEDIS-EuroSCape project. Attention has been paid to design principles and features of a communication scheme that must be used to support cooperative problem solving within a network of loosely connected autonomous and hetereogeneous agents. Experience confirmed two key-success factors: a) the users leading role, and b) the Pilot approach putting the focus on standardized electronic data interchange for communicating existing different local systems.
J L Monteagudo
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Studies in health technology and informatics     Volume:  28     ISSN:  0926-9630     ISO Abbreviation:  Stud Health Technol Inform     Publication Date:  1996  
Date Detail:
Created Date:  1997-02-11     Completed Date:  1997-02-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9214582     Medline TA:  Stud Health Technol Inform     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  69-77     Citation Subset:  T    
Institute of Health Carlos III, Health Services Research Unit, Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adverse Drug Reaction Reporting Systems* / standards
Computer Communication Networks*
Computer Systems
Information Systems*
Pilot Projects

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Medical device vigilance at FDA.
Next Document:  Finland's competent authority initiatives.